Ronald Herbst,Elizabeth K. Ward,Kathleen Phillips McKeever
申请号：
US13885219
公开号：
US20130330328A1
申请日:
2011.11.14
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present disclosure provides methods for treating B cell lymphomas using a combination of anti-CD19 and anti-CD20 antibodies. Such methods provide therapeutic advantages over single antibody therapies, including prolonged anti-tumor activity and/or reduced dosages.
